GlaxoSmithKline (LSE: GSK) is often pegged as a super-safe income stock due to the rock solid demand for drugs — and its 5.8% dividend yield — but the fact is this business is in transition and at the moment its payout looks perilously uncovered. However, there’s a reason to be optimistic… sort of.
Is GlaxoSmithKline plc’s Dividend Safe?
VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) under the spotlight.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.